Skip to main content
. Author manuscript; available in PMC: 2013 Jul 22.
Published in final edited form as: Methods Mol Biol. 2013;963:303–317. doi: 10.1007/978-1-62703-230-8_18

Figure 1.

Figure 1

Strategy for the discovery and development of SBiXs. An iterative process that includes computer-aided drug design (CADD), high-throughput screening (HTS), structure/activity (SAR) and medicinal chemistry, 3D structure (NMR and X-ray), and a specificity filter is used to engineer modified SBiXs for intratumoral in vivo screening and subsequent advanced leads suitable for preclinical evaluation.